{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:04:03Z","timestamp":1791223443551,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor Necrosis Factor (TNF) is a pleiotropic cytokine consisting of soluble and transmembrane forms, with distinct roles in inflammation and immunity. TNF is an important factor in allergic airway inflammation. However, the disparate functions of soluble (sol) and transmembrane (tm) TNF in lung pathology are not well understood. Our aim was to assess the activities of solTNF and tmTNF in murine models of allergic airway disease, and to evaluate the efficacy of solTNF-selective inhibition. We used ovalbumin sensitization and challenge of TNF knockout, tmTNF knockin, and wild-type C57BL\/6 mice to distinguish differences in airway inflammation and hyperreactivity mediated by solTNF and tmTNF. Functions of solTNF and tmTNF in hyperresponsive, wild-type Balb\/c mice were assessed by comparing dominant-negative anti-TNF biologics, which antagonize solTNF yet spare tmTNF, to etanercept, a nonselective inhibitor of both TNF forms. Responses in transgenic C57BL\/6 mice demonstrated that solTNF, and not tmTNF, is necessary to drive airway inflammation. In Balb\/c mice, dominant-negative TNF biologics administered during immunization decreased the recruitment of eosinophils and lymphocytes into the bronchoalveolar space and lung parenchyma, reduced specific serum IgE, goblet-cell hyperplasia, and eosinophilic inflammation, and suppressed methacholine-induced airway hyperreactivity. Concentrations of IL-5, CCL5\/RANTES, CCL11\/eotaxin, and CCL17\/TARC were also reduced in bronchoalveolar lavage. Dominant-negative TNFs reduced lung eosinophilia, even when given only during antigen challenge. The selective inhibition of soluble TNF suppresses inflammation, hyperreactivity, and remodeling in transgenic and wild-type murine models of allergic airway disease, and may offer safety advantages in therapies that preserve the immunoprotective functions of transmembrane TNF.<\/jats:p>","DOI":"10.1165\/rcmb.2010-0512oc","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T00:20:40Z","timestamp":1296865240000},"page":"731-739","source":"Crossref","is-referenced-by-count":26,"title":["Allergic Lung Inflammation Is Mediated by Soluble Tumor Necrosis Factor (TNF) and Attenuated by Dominant-Negative TNF Biologics"],"prefix":"10.1093","volume":"45","author":[{"given":"Isabelle","family":"Maillet","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Immunology and Embryology, University of Orl\u00e9ans, Orl\u00e9ans, France"},{"name":"UMR6218 Centre National de la Recherche Scientifique, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Schnyder-Candrian","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Embryology, University of Orl\u00e9ans, Orl\u00e9ans, France"},{"name":"UMR6218 Centre National de la Recherche Scientifique, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Couillin","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Embryology, University of Orl\u00e9ans, Orl\u00e9ans, France"},{"name":"UMR6218 Centre National de la Recherche Scientifique, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie F. J.","family":"Quesniaux","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Embryology, University of Orl\u00e9ans, Orl\u00e9ans, France"},{"name":"UMR6218 Centre National de la Recherche Scientifique, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Erard","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Embryology, University of Orl\u00e9ans, Orl\u00e9ans, France"},{"name":"UMR6218 Centre National de la Recherche Scientifique, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Moser","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Klinische Biomedizinische Forschung Thurgau (IKBT), Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Fleury","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1011, Universit\u00e9 Lille Nord de France and Institut Pasteur de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kanda","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1011, Universit\u00e9 Lille Nord de France and Institut Pasteur de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dombrowicz","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1011, Universit\u00e9 Lille Nord de France and Institut Pasteur de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Szymkowski","sequence":"additional","affiliation":[{"name":"Xencor, Inc., Monrovia, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ryffel","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Embryology, University of Orl\u00e9ans, Orl\u00e9ans, France"},{"name":"UMR6218 Centre National de la Recherche Scientifique, Orl\u00e9ans, France"},{"name":"Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"key":"2026021904113532300_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.immunol.17.1.255","article-title":"Immunologic basis of antigen-induced airway hyperresponsiveness","volume":"17","author":"Wills-Karp","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"2026021904113532300_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-152-4-201002160-00008","article-title":"Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes","volume":"152","author":"Levine","year":"2010","journal-title":"Ann Intern Med"},{"key":"2026021904113532300_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/thx.2005.045260","article-title":"Tumour necrosis factor (TNF\u03b1) as a novel therapeutic target in symptomatic corticosteroid dependent asthma","volume":"60","author":"Howarth","year":"2005","journal-title":"Thorax"},{"key":"2026021904113532300_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0091-6749(92)90218-Q","article-title":"Cytokines in symptomatic asthma airways","volume":"89","author":"Broide","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/ajrccm\/145.2_Pt_1.332","article-title":"Tumor necrosis factor causes bronchial hyperresponsiveness in rats","volume":"145","author":"Kips","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026021904113532300_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.coph.2007.03.001","article-title":"TNF-\u03b1 in asthma","volume":"7","author":"Berry","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"2026021904113532300_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2006.09.024","article-title":"Biologic immune modifiers: trials and tribulations: are we there yet?","volume":"118","author":"Ballow","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2006.11.701","article-title":"TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice","volume":"119","author":"Nakae","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaci.2007.02.046","article-title":"Mast cell\u2013derived TNF contributes to airway hyperreactivity, inflammation, and Th2 cytokine production in an asthma model in mice","volume":"120","author":"Nakae","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2222.2005.02407.x","article-title":"Anti-tumor necrosis factor\u2013\u03b1 antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust","volume":"36","author":"Kim","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"2026021904113532300_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2249.2007.03509.x","article-title":"Tumour necrosis factor\u2013\u03b1 blockade suppresses murine allergic airways inflammation","volume":"151","author":"Hutchison","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2026021904113532300_bib12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jaci.2005.08.059","article-title":"Chronic exposure to TNF-\u03b1 increases airway mucus gene expression in vivo","volume":"116","author":"Busse","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2026021904113532300_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10238-005-0080-5","article-title":"Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease","volume":"5","author":"Prete","year":"2005","journal-title":"Clin Exp Med"},{"key":"2026021904113532300_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/rccm.200601-072OC","article-title":"The effects of a monoclonal antibody directed against tumor necrosis factor\u2013\u03b1 in asthma","volume":"174","author":"Erin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904113532300_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor \u03b1 in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"2026021904113532300_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2007.06.031","article-title":"Asthma therapy and airway remodeling","volume":"120","author":"Mauad","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jaci.2007.10.028","article-title":"Amrani Y. Targeting TNF-\u03b1: a novel therapeutic approach for asthma","volume":"121","author":"Brightling","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904113532300_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","article-title":"A randomized, double-blind, placebo-controlled study of tumor necrosis factor\u2013\u03b1 blockade in severe persistent asthma","volume":"179","author":"Wenzel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904113532300_bib20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0002-9440(10)62331-0","article-title":"Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-Gu\u00e9rin and Mycobacterium tuberculosis infections","volume":"166","author":"Olleros","year":"2005","journal-title":"Am J Pathol"},{"key":"2026021904113532300_bib21","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","article-title":"Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection","volume":"179","author":"Zalevsky","year":"2007","journal-title":"J Immunol"},{"key":"2026021904113532300_bib22","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/eji.200635921","article-title":"Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity","volume":"36","author":"Alexopoulou","year":"2006","journal-title":"Eur J Immunol"},{"key":"2026021904113532300_bib23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1086\/597204","article-title":"Dominant-negative tumor necrosis factor protects from Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis","volume":"199","author":"Olleros","year":"2009","journal-title":"J Infect Dis"},{"key":"2026021904113532300_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2567.2008.02865.x","article-title":"Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection","volume":"125","author":"Allie","year":"2008","journal-title":"Immunology"},{"key":"2026021904113532300_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"2026021904113532300_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2009.01.002","article-title":"Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor","volume":"131","author":"Kaymakcalan","year":"2009","journal-title":"Clin Immunol"},{"key":"2026021904113532300_bib27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"Steed","year":"2003","journal-title":"Science"},{"key":"2026021904113532300_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jhep.2010.05.029","article-title":"Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis","volume":"53","author":"Olleros","year":"2010","journal-title":"J Hepatol"},{"key":"2026021904113532300_bib29","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J Neurosci"},{"key":"2026021904113532300_bib30","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/mt.2008.146","article-title":"Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats","volume":"16","author":"McCoy","year":"2008","journal-title":"Mol Ther"},{"key":"2026021904113532300_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol Dis"},{"key":"2026021904113532300_bib32","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti-tumor necrosis factor \u03b1 VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis","volume":"54","author":"Coppieters","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026021904113532300_bib33","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.4049\/jimmunol.151.11.6602","article-title":"Influence of a recombinant human soluble tumor necrosis factor receptor Fc fusion protein on Type II collagen-induced arthritis in mice","volume":"151","author":"Wooley","year":"1993","journal-title":"J Immunol"},{"key":"2026021904113532300_bib34","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.94.15.8093","article-title":"Characterization of tumor necrosis factor\u2013deficient mice","volume":"94","author":"Marino","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021904113532300_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1074-7613(01)00215-1","article-title":"Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation","volume":"15","author":"Ruuls","year":"2001","journal-title":"Immunity"},{"key":"2026021904113532300_bib36","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.173.5.3281","article-title":"Arthropod-derived histamine-binding protein prevents murine allergic asthma","volume":"173","author":"Couillin","year":"2004","journal-title":"J Immunol"},{"key":"2026021904113532300_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nm1718","article-title":"Breast milk\u2013mediated transfer of an antigen induces tolerance and protection from allergic asthma","volume":"14","author":"Verhasselt","year":"2008","journal-title":"Nat Med"},{"key":"2026021904113532300_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4049\/jimmunol.175.1.262","article-title":"Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome","volume":"175","author":"Schnyder-Candrian","year":"2005","journal-title":"J Immunol"},{"key":"2026021904113532300_bib39","doi-asserted-by":"crossref","first-page":"L394","DOI":"10.1152\/ajplung.2001.281.2.L394","article-title":"Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung","volume":"281","author":"Takeda","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021904113532300_bib40","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20050584","article-title":"No audible wheezing: nuggets and conundrums from mouse asthma models","volume":"201","author":"Boyce","year":"2005","journal-title":"J Exp Med"},{"key":"2026021904113532300_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1183\/09031936.03.00026403","article-title":"Murine models of asthma","volume":"22","author":"Kips","year":"2003","journal-title":"Eur Respir J"},{"key":"2026021904113532300_bib42","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","article-title":"Infections in patients with rheumatoid arthritis treated with biologic agents","volume":"52","author":"Listing","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2026021904113532300_bib43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/rheumatology\/keh567","article-title":"TNF-blocking agents and tuberculosis: new drugs illuminate an old topic","volume":"44","author":"Keane","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"2026021904113532300_bib44","first-page":"35","article-title":"Why does tumor necrosis factor targeted therapy reactivate tuberculosis?","volume":"74","author":"Ehlers","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"2026021904113532300_bib45","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9440(10)61250-3","article-title":"Membrane tumor necrosis factor confers partial protection to Listeria infection","volume":"167","author":"Torres","year":"2005","journal-title":"Am J Pathol"},{"key":"2026021904113532300_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1465-9921-6-136","article-title":"Membrane TNF confers protection to acute mycobacterial infection","volume":"6","author":"Fremond","year":"2005","journal-title":"Respir Res"},{"key":"2026021904113532300_bib47","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.4049\/jimmunol.174.8.4852","article-title":"Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection","volume":"174","author":"Saunders","year":"2005","journal-title":"J Immunol"},{"key":"2026021904113532300_bib48","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/eji.200737662","article-title":"An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection","volume":"38","author":"Allenbach","year":"2008","journal-title":"Eur J Immunol"},{"key":"2026021904113532300_bib49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/517519","article-title":"Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis","volume":"195","author":"Plessner","year":"2007","journal-title":"J Infect Dis"},{"key":"2026021904113532300_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11882-007-0013-3","article-title":"Tumor necrosis factor inhibitors for the treatment of asthma","volume":"7","author":"Kim","year":"2007","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/45\/4\/731\/66923234\/ajrcmb_45_4_731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/45\/4\/731\/66923234\/ajrcmb_45_4_731.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:11:50Z","timestamp":1771492310000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/45\/4\/731\/8483767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,10,1]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2010-0512oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,10,1]]}}}